These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6222632)

  • 1. Plasmin induced changes in high molecular weight kininogen (HMW-K).
    Kleniewski J; Donaldson VH; Wagner CJ
    Adv Exp Med Biol; 1983; 156():165-73. PubMed ID: 6222632
    [No Abstract]   [Full Text] [Related]  

  • 2. Some molecular and functional changes in high molecular weight kininogen induced by plasmin and trypsin.
    Kleniewski J; Donaldson VH; Wagner CJ
    Thromb Res; 1982 Mar; 25(5):387-99. PubMed ID: 6176044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.
    Scott CF; Colman RW
    J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma high molecular weight kininogen concentration in health and in chosen impairments of haemostasis. Evidence that plasmin uncovers a new antigenic site in high molecular weight kininogen.
    Kleniewski J
    Thromb Haemost; 1979 Oct; 42(3):1046-55. PubMed ID: 92069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
    Donaldson VH; Kleniewski J; Saito H; Sayed JK
    J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
    Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
    J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical studies of human kininogen.
    Kerbiriou DM; Griffin JH; Larrieu MJ
    Adv Exp Med Biol; 1983; 156():233-40. PubMed ID: 6858754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of HMW kininogen in surface-mediated activation of Factor XII.
    Shimada T; Sugo T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():73-85. PubMed ID: 6134440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation.
    Bouma BN; Kerbiriou DM; Vlooswijk RA; Griffin JH
    J Lab Clin Med; 1980 Oct; 96(4):693-709. PubMed ID: 6903191
    [No Abstract]   [Full Text] [Related]  

  • 12. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological studies of human Factor XI and prekallikrein: demonstration of complex formation with high molecular weight kininogen.
    Bouma BN; Vlooswijk RA; Griffin JH
    Adv Exp Med Biol; 1983; 156():109-13. PubMed ID: 6552836
    [No Abstract]   [Full Text] [Related]  

  • 14. Tachibana trait: human high molecular weight kininogen deficiency with diminished levels of prekallikrein and low molecular weight kininogen.
    Nakamura K; Iijima K; Fukuda C; Kadowaki H; Ikoma H; Oh-ishi S; Uchida Y; Katori M
    Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1473-9. PubMed ID: 3853954
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bovine high molecular weight kininogen and its fragments on Fitzgerald trait plasma.
    Waldmann R; Scicli AG; McGregor RK; Carretero OA; Abraham JP; Kato H; Han YN; Iwanaga S
    Thromb Res; 1976 Jun; 8(6):785-95. PubMed ID: 960054
    [No Abstract]   [Full Text] [Related]  

  • 17. HMW and LMW kininogens.
    Kato H; Nagasawa S; Iwanaga S
    Methods Enzymol; 1981; 80 Pt C():172-98. PubMed ID: 7043190
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes of high molecular weight kininogen in various states].
    Sano M
    Rinsho Ketsueki; 1989 Oct; 30(10):1708-12. PubMed ID: 2593237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen.
    Gordon EM; Ratnoff OD; Goldsmith GH
    J Lab Clin Med; 1980 Apr; 95(4):507-14. PubMed ID: 7359011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.